News
Coca-Cola Q4 Earnings Beat Estimates, Stock Falls on Revenues Miss
The Coca-Cola Company KO has reported fourth-quarter 2025 results, with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same. The company’s revenues and earnings
Fiserv Q4 Earnings Beat Estimates, Revenues Decline 7% Y/Y
Fiserv, Inc. FISV has reported mixed fourth-quarter 2025 results, wherein earnings beat the Zacks Consensus Estimate, while revenues missed the same.
FISV’s adjusted earnings per share of $1.99
Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth?
DexCom, Inc. DXCM is scheduled to report fourth-quarter 2025 results on Feb. 12, after the closing bell.
In the last reported quarter, the company’s adjusted earnings per share (EPS) of 61 cents
Howmet Q4 Earnings Preview: Should You Buy the Stock Now or Wait?
Howmet Aerospace Inc. HWM is scheduled to release fourth-quarter 2025 results on Feb. 12, before market open. The Zacks Consensus Estimate for earnings is currently pegged at 97 cents per share on
OpenClaw: Agentic AI's "ChatGPT Moment"
2026: Agentic AI (From Chat to Action)
Thus far in the AI boom, investors have been hyper-focused on chatbots and large language models (LLMs) like ‘Gemini’ and ‘ChatGPT.’ Chatbots are a focus
Ahead of Q4 Earnings, CoreWeave Is Up 142% Over the Past Year
While software stocks remain under pressure and the majority of the Magnificent Seven continue to trail the broad market, investors going all-in on the rotation into defensive sectors—such as ener
HAIN Stock Falls 20% After Reporting Q2 Loss & Y/Y Sales Decline
The Hain Celestial Group, Inc. HAIN posted second-quarter fiscal 2026 results, with the top and bottom lines declining year over year. The top line surpassed the consensus mark and the bottom line
Mohawk Gears to Post Q4 Earnings: What's in Store this Season?
Mohawk Industries, Inc. MHK is scheduled to report results for its fourth quarter of 2025 on Feb. 12, after market close.In the last reported quarter, the company’s adjusted earnings per share (EPS)
NIKE Stock Breaks Below 50-Day SMA: Buying Sign or Time to Exit?
Shares of NIKE Inc. NKE have lost momentum in recent months, pushing it below industry thresholds and portraying a bearish sentiment from a technical standpoint. As a result, the NKE stock slipped
December Retail Sales Came in Flat
Pre-market indexes are pulling back slightly this morning, following another record close from the blue-chip Dow on Monday. Spirits are generally higher than they were trying to scale the “wall of
Cincinnati Financial Q4 Earnings Beat Estimates on Underwriting Income
Cincinnati Financial Corporation CINF reported fourth-quarter 2025 operating income of $3.37 per share, which surpassed the Zacks Consensus Estimate by 17.8%. The bottom line increased 7% year over
Arch Capital Tops Q4 Earnings Estimates on Solid Underwriting
Arch Capital Group Ltd. ACGL reported fourth-quarter 2025 operating income of $2.98 per share, which beat the Zacks Consensus Estimate by 19.7%. The bottom line increased 31.9% year over year.
Vale is Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
Vale S.A. VALE is expected to post year-over-year growth in revenues and earnings when it reports fourth-quarter 2025 results on Feb. 12, after market close.
The Zacks Consensus Estimate for Vale’s
DuPont Tops Earnings Estimates in Q4, Reports Flat Y/Y Sales
DuPont de Nemours, Inc. DD has registered a fourth-quarter 2025 loss from continuing operations of $108 million or 27 cents per share. In the year-ago quarter, the company recorded a loss of $291
ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
Zimmer Biomet Holdings, Inc. ZBH posted fourth-quarter 2025 adjusted earnings per share (EPS) of $2.42, which beat the Zacks Consensus Estimate by 1.7%. The adjusted figure rose 4.8% year over year.
EQNR Secures Contract to Supply Gas to Eneco for Netherlands
Equinor ASA EQNR signed a five-year gas supply deal with Dutch gas grid operator Eneco to supply natural gas to the Netherlands. Per the terms of the deal, Equinor will deliver up to 0.5 billion
LLY Expands Cell Therapy Ambitions With $2.4B Orna Therapeutics Deal
Eli Lilly LLY announced that it entered a definitive agreement to acquire the privately held clinical-stage biotech Orna Therapeutics in a deal valued at $2.4 billion. This transaction includes both
Will BMY's Legacy Portfolio Decline Weigh on Its 2026 Top Line?
Bristol Myers’ BMY legacy portfolio — comprising Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane — continues to face significant erosion from generic competition.
Fourth-quarter legacy portfolio
Goodyear Q4 Earnings Miss Expectations, Revenues Decline Y/Y
Goodyear Tire GT reported fourth-quarter 2025 adjusted earnings per share of 39 cents, which missed the Zacks Consensus Estimate of 45 cents. The company reported earnings of 39 cents per share in
Harley Q4 Earnings Miss Expectations, Revenues Fall Y/Y
Harley-Davidson, Inc. HOG reported a loss of $2.44 per share in fourth-quarter 2025, wider than the Zacks Consensus Estimate of a loss of 92 cents. The company had incurred a loss of 93 cents per
ASH's Agrimer Eco-Coat Gets EPA Approval for Pesticide Use in the US
Ashland Inc. ASH announced that its agrimer eco-coat polymer seed coating for crop care has been officially posted and approved by the United States Environmental Protection Agency. The new
Sally Beauty Raises Low End of FY26 EPS View on Q1 Earnings Beat
Sally Beauty Holdings, Inc. SBH reported fiscal first-quarter 2026 results, wherein the top line came slightly below the Zacks Consensus Estimate, while the bottom line beat the Zacks Consensus


